Wyeth Pharmaceuticals India Profile
Key Indicators
- Authorised Capital ₹ 7.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 6.70 Cr
as on 16-11-2024
- Company Age 18 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 117.18%
(FY 2023)
- Profit -7.11%
(FY 2023)
- Ebitda 51.70%
(FY 2023)
- Net Worth 1.38%
(FY 2023)
- Total Assets 1.26%
(FY 2023)
About Wyeth Pharmaceuticals India
The Corporate was formerly known as Wyeth Pharmaceuticals India Limited. The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.00 Cr and a paid-up capital of Rs 6.70 Cr, as per Ministry of Corporate Affairs (MCA) records.
Prajeet Nair and Darshak Bhagat serve as directors at the Company.
- CIN/LLPIN
U24230MH2006PTC159507
- Company No.
159507
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Feb 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Wyeth Pharmaceuticals India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prajeet Nair  | Director | 07-May-2015 | Current |
| Darshak Bhagat | Director | 30-Mar-2020 | Current |
Financial Performance and Corporate Structure Insights of Wyeth Pharmaceuticals India.
Wyeth Pharmaceuticals India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 117.18% increase. The company also saw a slight decrease in profitability, with a 7.11% decrease in profit. The company's net worth moved up by a moderate rise of 1.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Wyeth Pharmaceuticals India?
In 2022, Wyeth Pharmaceuticals India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Wyeth Pharmaceuticals India?
Unlock and access historical data on people associated with Wyeth Pharmaceuticals India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Wyeth Pharmaceuticals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wyeth Pharmaceuticals India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
